Novo Nordisk, Genentech and Sanofi to cut off jobs in 2018

 Novo Nordisk, Genentech and Sanofi to cut off jobs in 2018

Novo Nordisk, Genentech and Sanofi to cut off jobs in 2018

     Shots:

  • Novo Nordisk lay off nearly 250 employees in US due to slow revenue growth, and they will hire undetermined numbers of new employees in new positions
  • Genentech to cutback 223 job in their South San Francisco HQ due decline in sales due to biosimilar version of MabThera/Rituxan and the sales of Herceptin and MabThera have fallen by 5% & 9% resp. The company providing financial benefits, extended insurance coverage and job placement assistance to the employees
  •  Sanofi to cut down 670 jobs in France by 2020, additionally the company to invest 804.5M in France to raise its production sites 

Click here Novo Nordisk, Sanofi to read full press release/ article | Ref: Novo Nordisk, Genentech and Sanofi | Image: The Balance Careers

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post